Results 181 to 190 of about 490,962 (254)

A Pharmacogenomics‐Guided Antihypertensive Strategy for Blood Pressure Reduction in Rural China: A Cluster‐Randomized Controlled Trial

Health Care Science, EarlyView.
This manuscript reports the findings from the Pharmacogenomic‐guided Antihypertensive Strategy Trial study amidst the deteriorating blood pressure control observed globally during the COVID‐19 pandemic. A pharmacogenomics‐guided strategy achieved a 98.4% blood pressure control rate at 4 weeks in rural China.
Wangjun Qin, Mengke Yu, Ying Zhu, Queran Lin, Limei Yin, Guisheng Liu, Yaping Wang, Guangqiang Lu, Xiaofei Liu, Pengmei Li, Xudong Kong, Li Zhao, Kun Tang, Jiangli Jin, Yu Xiong, Yingnan Zhao, Yan Yan, Bo Li, Azeem Majeed, Xianbo Zuo, Yue Qiu, Jiantuo Yu, Lihong Liu   +22 more
wiley   +1 more source

Current status of hepatitis C treatment and its barriers in Jeonbuk, Republic of Korea. [PDF]

Osong Public Health Res Perspect
Kang JH, Moon YJ, Kim UG, Park JI, Lee CH, Kim IH, Lee JH, Gwack J.   +7 more
europepmc   +1 more source

The Effects of Compulsory Licensing: A Case Study of HIV Drugs

Health Economics, EarlyView.
ABSTRACT Compulsory licensing is a legal mechanism that allows governments the use of patented medicines without the owner's consent, subject to conditions and compensation, to meet public‐health needs. Despite its policy relevance and increasing use, empirical evidence on its market effects remains limited.
Nicolau Martin‐Bassols, Miquel Serra‐Burriel, Kerstin Noelle Vokinger   +2 more
wiley   +1 more source

Risk of hepatitis C transmission by healthcare workers - a systematic review. [PDF]

GMS Hyg Infect Control
Diel R, Nienhaus A.
europepmc   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

Head &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell, E. C. Ward, L. R. Wishart, R. Perera, C. Barrett, K. A. Edmiston, E. Mitchell, A. Pigott, R. Pitt, K. Russell, B. A. Chan, R. Ladwa   +11 more
wiley   +1 more source

Hepatitis C Treatment by Early-Career US Family Physicians. [PDF]

Fam Med
Topmiller M, Peterson LE, Carrozza MA, Vissman AT, Visconti A, Bazemore AW.   +5 more
europepmc   +1 more source

The Hepatitis C Cascade of Care for Opioid Agonist Therapy Recipients in Australia. [PDF]

Clin Infect Dis
Griffin S, Asselin J, Wilkinson AL, Traeger MW, Pedrana A, Winter RJ, Thompson AJ, Penn M, Dimech W, Donovan B, Hellard M, Stoové M.   +11 more
europepmc   +1 more source

Management of hepatitis C infections among Rohingya refugees, Bangladesh. [PDF]

Bull World Health Organ
Ceccarelli G, Branda F, Fairouz F, Albanese M, Scarpa F, d'Ettorre G, Giovanetti M, Ngwabe Che T, Ciccozzi M.   +8 more
europepmc   +1 more source

Trends in Utilization and Costs Following a Hepatitis C Elimination Initiative. [PDF]

JAMA Netw Open
Tabah A, Basu A, Cox-North P, Zerzan-Thul J, Evaskus L, Sullivan D, Colson J, Huriaux E, Stockton J, Heidari O, Wiggins L, Chang S, Kohler P.   +12 more
europepmc   +1 more source